BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10431752)

  • 1. Z-350, a new chimera compound possessing alpha1-adrenoceptor antagonistic and steroid 5alpha-reductase inhibitory actions.
    Fukuda Y; Fukuta Y; Higashino R; Ogishima M; Yoshida K; Tamaki H; Takei M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):433-8. PubMed ID: 10431752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
    Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal effects of Z-350, possessing steroid 5alpha-reductase inhibitory and alpha1-adrenoceptor antagonistic actions, in the rat.
    Fukuda Y; Fukuta Y; Higashino R; Yoshida K; Ogishima M; Takei M; Kurimoto T
    Jpn J Pharmacol; 2001 Jul; 86(3):323-8. PubMed ID: 11488433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of alpha1-adrenoceptor subtypes in rat aorta and prostate.
    Maruyama K; Suzuki M; Tsuchiya M; Makara Y; Hattori K; Ohnuki T; Watanabe K; Nagatomo T
    Pharmacology; 1998 Aug; 57(2):88-95. PubMed ID: 9691228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of alpha1-adrenoceptor subtypes in rabbit aorta and arteries: regional difference and co-existence.
    Satoh M; Enomoto K; Takayanagi I; Koike K
    Eur J Pharmacol; 1999 Jun; 374(2):229-40. PubMed ID: 10422764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha(1A/L)-adrenoceptors mediate contraction of the circular smooth muscle of the pig urethra.
    Bagot K; Chess-Williams R
    Auton Autacoid Pharmacol; 2006 Oct; 26(4):345-53. PubMed ID: 16968473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic analysis of steroid 5alpha-reductase inhibitory actions of Z-350 in rat prostate.
    Furuta S; Fukuda Y; Sugimoto T; Miyahara H; Kamada E; Sano H; Fukuta Y; Takei M; Kurimoto T
    Eur J Pharmacol; 2001 Aug; 426(1-2):105-11. PubMed ID: 11525778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig.
    Barbieri A; Santagostino-Barbone MG; Zonta F; Lucchelli A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):654-61. PubMed ID: 9686942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
    Smith KM; Macmillan JB; McGrath JC
    Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta.
    Yamagishi R; Akiyama K; Nakamura S; Hora M; Masuda N; Matsuzawa A; Murata S; Ujiie A; Kurashina Y; Iizuka K; Kitazawa M
    Eur J Pharmacol; 1996 Nov; 315(1):73-9. PubMed ID: 8960867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S; Taniguchi T; Muramatsu I
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.
    Alexandre EC; Kiguti LR; Calmasini FB; Silva FH; da Silva KP; Ferreira R; Ribeiro CA; Mónica FZ; Pupo AS; Antunes E
    Br J Pharmacol; 2016 Feb; 173(3):415-28. PubMed ID: 26493129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.
    Nakamura S; Taniguchi T; Suzuki F; Akagi Y; Muramatsu I
    Br J Pharmacol; 1999 Jul; 127(6):1367-74. PubMed ID: 10455286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro.
    Ibarra M; Hong E; Villalobos-Molina R
    J Auton Pharmacol; 2000 Jun; 20(3):139-45. PubMed ID: 11193002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.